|Articles|June 2, 2022
ActiGraph Establishes New Scientific Advisory Board
Advertisement
ActiGraph has formally established an advisory board of leading digital and clinical research experts to guide its scientific strategy.
The members of this new Scientific Advisory Board were selected for their experience in using digital health technologies across a wide spectrum of therapeutic areas. These perspectives will provide ActiGraph with guidance to ensure the company’s platform and solutions are optimized and fit-for-purpose for clinical research and care.
The first five members are: Rohit Aggarwal, MD, Tina Duong, MPT, PhD, Richard Keefe, PhD, Emmanuel Mignot, MD, PhD, and Eric Perakslis, PhD.
Read more about the advisory board and its first members
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
2
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
3
ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment
4
The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research
5